European Biotechnology Guide 2024

Pmvch - Freepik.com

adline e D g n i Book 2024 y r a u r 12 Feb

Reserve your entry now!

Spotlight on Europe’s Biotechnology Industry!

The “14th European Biotechnology Science & Industry Guide 2024” – the handbook that presents the strengths and core competencies of companies and institutions in the fields of Biotech, Biopharma, BioServices and BioManufacturing in Europe. Besides the printed version the guide will also be available as a digital version.

International Distribution Print & Digital!

Date n o i t a c i l Pub 2024 h c r a 13 M

14th European Biotechnology Science & Industry Guide 2024 Publication date: March 13, 2024 Print run 10,000+ hard copies In cooperation with the European Biotechnology Network Distribution at major life sciences events throughout the year (planned): ∙ BIO-Europe Spring 2024, 18-20 March, Barcelona ∙ Swiss Biotech Day 2024, 22-23 April, Basel ∙ Renewable Materials Conference 2024, 11-13 June, Siegburg/Cologne ∙ ACHEMA 2024, 10-14 June, Frankfurt/Main ∙ Chemspec Europe 2024, 19-20 June, Duesseldorf ∙ CPhI Milan 2024, 08-10 October, Milan ∙ BIO Europe 2024, 04-06 November, Stockholm ∙ BioFIT 2024, December, Lille

lso in a e l fi o r Your p on! i s r e v l a the digit

Online: PREMIER RESEARCH

Name › Premier Research Address/P.O. Box › 3800 Paramount Parkway Postal Code/City › Suite 400, Morrisville, NC 27560 Country › USA Subsidiary › Premier Research (Germany) Address/P.O. Box › Europaplatz 5 Postal Code/City › 64293 Darmstadt Country › Germany Contact Person › Raphaela Schnurbus Telephone › +49-6151-5201600 Fax › +49-6151-5201602 Email › raphaela.schnurbus@ premier-research.com Website › https://premier-research.com/

Premier Research is a clinical research, product development, and consulting company dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments.

As a global company, Premier Research specialises in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors.

Our Approach We are continually optimising our processes to deliver the right mix of agility and knowledge to support our most innovative biotech and specialty pharma sponsors.

Social Media › L I Number of Employees › 2,400+ Founded (year) › 1989 Areas of Activity › Biotech, Specialty Pharma, Rare Diseases, Cell & Gene Therapy, Oncology, Analgesia, Dermatology, Neuroscience, Pediatrics, Women’s Health, Medical Devices, Diagnostics, Real-World Science & Late Phase Research

What we do Your compound shows spectacular promise, but it seems there’s an obstacle at every turn – finding hardto-reach patients, defining relevant endpoints, navigating the regulatory maze, and ultimately obtaining clean, conclusive data.

Our Built for Biotech model is a compilation of the most successful techniques and capabilities observed across our experience, applied to provide a specialised customer experience.

Collaborative Approach We are committed to helping our customers answer the unmet needs of patients across a broad range of medical conditions.

Our specialised global task forces are dedicated to smart study optimisation and risk management throughout the trial to support drug development strategies.

Therapeutically focused teams of clinical professionals have the knowledge and experience necessary to effectively manage any situation that may arise in your trial. Our approach is firmly grounded in comprehensive project management principles and well-defined processes.

The digital version of the guide containing all profiles will be available via download for 22,000+ newsletter subscribers of european-biotechnology.com.

Amazing Science It’s amazing and often very complex science, and we’ve positioned ourselves right in the middle of the action, where pioneers are doing the most exciting work.

Whether you’re a single-compound start-up or more interested in pursuing science than in negotiating the arcane maze of protocol review and recruitment modeling, we can help with planning, design, execution, and conclusive results.

More than just clinical services, we offer unique perspectives, intelligent study designs, and a relentless focus on compliance and providing conclusive data.

Conclusive Data We are constantly investing in innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors.

This allows us to continually improve on product development and study outcomes.

Consulting Premier Consulting is a strategic product development and global regulatory consulting partner dedicated to supporting the specialised needs of emerging biotech and specialty pharma companies. These small to midsize companies are the very heart of drug development.

Like them, we are dedicated to the patient journey and driven by the challenges of bringing new life-saving technologies to market.

Creative Solutions to Your Most Complex Product Development Challenges Wherever you are in the development life cycle, from raising funds and developing a regulatory strategy to patient recruitment and data analysis, we are positioned to help.

Our drug development and regulatory experts are relentlessly thorough, constantly asking why (and why not), taking nothing at face value, and being flexible enough to pivot and regroup when circumstances demand. We know biotech and understand the passion and commitment that drives our sponsors. It is what drives us, too.

13 TH EUROPEAN BIOTECHNOLOGY GUIDE 2023 138

| 139

Prices & Services 2-Page Company Profile: 1,280 € standard fee | 1,024 € reduced fee* 2 pages company article with up to 3,500 characters text, images and logo. inclusive: layout, proof reading, and free copies of the book for you (max 10 copies). *All previous clients safe 20%.

Bonus: Free entry in the digital version implementation of your company presentation from the pirinted guide into the digitale version without any extra costs.

Optional: Reprints/Leaflets of your profile On request you can order 1,000 reprints (4-colored) of your guide entry for about 280 € net.

Contact & Support: Wolfgang Gutowski | Email: w.gutowski@biocom.de | Tel. +49 30 2649 2135

Mock-Ups: kenoric/graphicriver.net

adline e D g n i Book 2024 y r a u r 12 Feb

Reservation Form for 2024 Edition PLEASE MAKE YOUR SELECTION We order our two page presentation in the “14th European Biotechnology Science & Industry Guide 2024” for the net price of 1,280 €. This includes layout, proof reading, up to 10 free copies of the book, and implementation into the mobile app version.

Number of free voucher copies: ...... (max. 10) We are entitled to 20% discount because we were already represented in former guide editions.

Additionally to our guide presentation we wish to order 1,000 extra reprints as a four-colour flyer for the net price of 280 €.

Questions? Please call +49 (0)30-264921-35 This order can be revoked within 10 days.

Company/Institution ·

..........................................................................

Name ·

..........................................................................

Address/P.O. Box ·

..........................................................................

Postal Code/City ·

..........................................................................

Country ·

..........................................................................

Telephone ·

..........................................................................

Fax ·

..........................................................................

Email ·

..........................................................................

Date ·

..........................................................................

Signature ·

..........................................................................

Stamp ·

..........................................................................

FA X +49 (0)30-264921-11 OR EMAIL: MARKETING@BIOCOM.DE

BIOCOM Interrelations GmbH Jacobsenweg 61 13509 Berlin | Germany